1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends

EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2025

  • June 2016
  • 69 pages
  • GlobalData
Report ID: 3389020

Summary

Table of Contents

Search Inside

EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2025

Summary

Type 2 diabetes (T2D), formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the body’s inability to make use of available insulin along with relative insulin deficiency. T2D constitutes approximately 90% of all diabetes cases around the world; type 1 diabetes (T1D) and gestational diabetes make up the remaining 10% of the cases. Risk factors for T2D are broadly categorized as either modifiable or non-modifiable risk factors. Lifestyle factors such as obesity, physical inactivity, and dietary habits are modifiable risk factors, whereas family history and advancing age are non-modifiable risk factors. T2D is also associated with several comorbidities, such as CKD, CVD, hypertension, and dyslipidemia, which can worsen the quality of life of the patient, and can lead to poor therapeutic outcomes. Diabetes is one of the most common non-communicable diseases worldwide and is an escalating public health problem globally.

GlobalData epidemiologists forecast an increase in the diagnosed prevalent cases of T2D in the 9MM, from 116,871,808 diagnosed prevalent cases in 2015 to 151,907,657 diagnosed prevalent cases in 2025, with an Annual Growth Rate (AGR) of 3.00%. The projected increase in the diagnosed prevalent cases of T2D across all the markets covered in this analysis is attributed to the actual increase in the incidence of T2D along with the change in population demographics in the respective markets.

GlobalData epidemiologists utilized country-specific diagnosed prevalence data for T2D across the 9MM. Additionally, the epidemiological forecast for the diagnosed prevalent cases of T2D in the 9MM is supported by nationally representative longitudinal historical data obtained from studies in respective countries published in peer-reviewed journals or national healthcare databases, which provide a detailed insight into the epidemiology of the disease in these markets.

Scope

- The Type 2 Diabetes (T2D) EpiCast Report provides an overview of the risk factors and global trends of T2D in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, China, and India). It includes a 10-year epidemiology forecast of T2D diagnosed prevalent cases segmented by age (in ten-year increments beginning at ages 20-30 years and ending at age 80 years and older), sex, and comorbidities including chronic kidney disease (CKD), cardiovascular disease (CVD), overweight/obesity, hypertension, and dyslipidemia in these nine markets.
- The T2D epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 9MM.

Reasons to buy

The T2D EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global T2D market.
- Quantify patient populations in the global T2D market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for T2D therapeutics in each of the markets covered.
- Identify the percentage of T2D diagnosed prevalent cases by age, sex, and comorbidities.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Global Market Study on Diabetic Foot Ulcer Therapeutics: Neuro-Ischemic Ulcers Segment to Dominate the Global Market in Revenue Terms Through 2024

  • $ 4900
  • Industry report
  • March 2017
  • by Persistence Market Research

In a new publication titled “Diabetic Foot Ulcer Therapeutics Market: Global Industry Analysis and Forecast, 2016–2024,” the analysts at Persistence Market Research have targeted five key geographies ...

Diabetic Retinopathy - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • May 2017
  • by Delve Insight

DelveInsight’s Diabetic Retinopathy - Epidemiology Forecast to 2023 Report provides an overview of the epidemiology trends of Diabetic Retinopathy in seven major markets (US, France, Germany, Italy, ...

Arterial Stiffness Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • April 2017
  • by GlobalData

Arterial Stiffness Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Arterial Stiffness Global Clinical Trials Review, H1, 2017" provides an overview of Arterial ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.